Review article: shared disease mechanisms between non-alcoholic fatty liver disease and metabolic syndrome - translating knowledge from systems biology to the bedside

Pharmacotherapy for NASH: Current and emerging

(2018) Monica A. Konerman et al.   JOURNAL OF HEPATOLOGY

Mechanisms of NAFLD development and therapeutic strategies

(2018) Scott L. Friedman et al.   NATURE MEDICINE

Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study

(2018) Galit Weinstein et al.   JAMA Neurology

Statins: Old drugs as new therapy for liver diseases?

(2018) Elisa Pose et al.   JOURNAL OF HEPATOLOGY

Liraglutide, sitagliptin and insulin glargine added to metformin: the effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and NAFLD

(2018) Jinhua Yan et al.   HEPATOLOGY

Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis

(2018) Mary E. Rinella et al.   JOURNAL OF HEPATOLOGY

Phenome-wide association studies across large population cohorts support drug target validation

(2018) Dorothée Diogo et al.   Nature Communications

Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

(2017) Leon A Adams et al.   GUT

Obesity as a risk factor for Alzheimer's disease: weighing the evidence

(2017) S. Alford et al.   Obesity Reviews

Nonalcoholic fatty liver disease and metabolic syndrome: Shared genetic basis of pathogenesis

(2016) Silvia Sookoian et al.   HEPATOLOGY

Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial

(2016) Jeffrey Cui et al.   JOURNAL OF HEPATOLOGY

Non-alcoholic fatty liver disease and risk of cardiovascular disease

(2016) Amedeo Lonardo et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma

(2015) Mazen Noureddin et al.   Clinics in Liver Disease

Nonalcoholic Fatty Liver Disease

(2015) Mary E. Rinella   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Nonalcoholic fatty liver disease

(2015) Elizabeth M. Brunt et al.   Nature Reviews Disease Primers

Potential of incretin-based therapies for non-alcoholic fatty liver disease

(2013) Susan L. Samson et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Platelet Granule Exocytosis: A Comparison with Chromaffin Cells

(2013) Jennifer L. Fitch-Tewfik et al.   Frontiers in Endocrinology

Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease

(2011) Silvia Sookoian et al.   ATHEROSCLEROSIS

Génie: literature-based gene prioritization at multi genomic scale

(2011) Jean-Fred Fontaine et al.   NUCLEIC ACIDS RESEARCH

Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation

(2010) Eckardt Treuter et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXR  in the hepatic acute phase response

(2010) N. Venteclef et al.   GENES & DEVELOPMENT

Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: Impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter

(2010) Silvia Sookoian et al.   HEPATOLOGY

ToppCluster: a multiple gene list feature analyzer for comparative enrichment clustering and network-based dissection of biological systems

(2010) V. Kaimal et al.   NUCLEIC ACIDS RESEARCH

Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model

(2009) Maria Soledad Rosselli et al.   ATHEROSCLEROSIS

Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease

(2009) Silvia Sookoian et al.   ATHEROSCLEROSIS

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

(2009) E. Fabbrini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review

(2008) Silvia Sookoian et al.   JOURNAL OF HEPATOLOGY